NewsRoom Articles - Page 149 of 151 - PsychedelicNewsWire (PNW)

FridayAug 04, 2017 3:24 pm

7 Company Updates from this Week to Review

The last week has been quite busy for the global marijuana industry as companies continued to execute and work to create value for shareholders. Although the marijuana industry is comprised of some incredible companies, investors must be selective and focus on the real players. Today we have highlighted 7 developments that marijuana stock investors need to know about. Insys: Second Quarter Revenue Drops 38% Nasdaq-traded Insys Therapeutics (INSY) reported its second quarter financial results today and recorded a 38% drop in revenue when compared to the same quarter last year. Although this biotech cannabis stock has continued to execute, the…

ThursdayJul 27, 2017 9:00 am

Biotech Players Lead the Growth Charge in the Legal Cannabis Market

PsychedelicNewsWire Editorial Coverage: The backbone of medical advancement is biotechnology, an industry wrought with the incredible potential of novel drug R&D, but vulnerable to the risk of stringent regulatory approval processes. Within this volatile market, however, is the cannabis-biotech sub-sector – a market flourishing with opportunity, innovation, and deep roots of medical possibilities. Fueled by an increasing volume of supportive research, cannabis-based biotech companies are addressing large markets of unmet medical need while rising to meet global demand of epic proportion. Included among several companies in the cannabis-biotech sub-sector is Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (LXRP Profile), a…

ThursdayJul 20, 2017 9:00 am

5 Standout Legal Cannabis Companies Worthy of Consideration

PsychedelicNewsWire Editorial Coverage: The legal marijuana market continues to gain momentum, driven by increasing public acceptance and an increasing number of investors looking for viable opportunities on a crowded playing field. According to a recent Gallup poll1, 60 percent of Americans now support the legalization of marijuana. As the playing field continues to grow in diversification and size, some of the most recognizable and frequently seen names are ChineseInvestors.com, Inc. (CIIX) (CIIX Profile), Terra Tech Corp. (TRTC), Medical Marijuana, Inc. (MJNA), Marijuana Company of America, Inc. (MCOA) and CV Sciences, Inc. (CVSI). The market presence of ChineseInvestors.com, Inc. (CIIX) is…

WednesdayJul 12, 2017 3:26 pm

ChineseInvestors.com, Inc. (CIIX) Aims to Become One-Stop-Shop for Chinese MMJ Patients

First online Chinese language cannabidiol (CBD) health products store Yelp-style mobile app for locating dispensaries and discussing cannabis products in the U.S. Investor consultancy and financial news service It appears that since antiquity, the Chinese have been aware of the therapeutic effect of cannabinoids. References in a manuscript with the authoritative title ‘Additional Records of Famous Physicians’, dating from the sixth century AD, point to their use as analgesics for “relieving impediment,” essentially the relief of pain. In a country with such a rich tradition of herbal remedies, cannabinoids have played an important role. Now, generations later, ChineseInvestors.com, Inc. (OTCQB:…

TuesdayJul 11, 2017 1:15 pm

Algae Dynamics Corp. (ADYNF) Changing the Dynamic of Plant Based Therapeutics

Proprietary system for high volume, low cost production of medicinal algae New research on botanical oil products derived from both cannabis and algae Combined health benefits of cannabis and algae create new exclusive market People have always relied on plants as a primary source of medicine and healing. Hundreds of remarkably common plants, herbs, and flowers continue to serve all kinds of important medicinal and health purposes. Various strains of algae offer high concentrations of vitamins, minerals, antioxidants and proteins. Brown algae have been used for weight loss, cancer, fibromyalgia, arthritis, stress, heart disease and high cholesterol. Blue-green algae, scientific studies indicate,…

ThursdayJun 22, 2017 9:00 am

Diverse Opportunities Aplenty for Investors Interested in the Marijuana Market

PsychedelicNewsWire Editorial Coverage: Within the exploding legalized marijuana industry, new innovations and investment opportunities are cropping up all the time; no matter what sector you have interest in, there is likely an investment option to be explored. Among enterprising companies looking for innovative ways to profit within the blossoming marijuana market, SinglePoint, Inc. (SING) (SING Profile), First Bitcoin Capital Corp. (BITCF), Kush Bottles, Inc. (KSHB), Medical Marijuana, Inc. (MJNA) and Solis Tek, Inc. (SLTK) offer diverse opportunities for savvy investors interested in a marijuana-related play. The growth of the legal marijuana market has been bigger and faster than the growth…

WednesdayJun 21, 2017 9:46 am

Algae Dynamics Corp. (ADYNF) is “One to Watch”

Algae Dynamics Corp (OTCQB: ADYNF) is focused on developing proprietary research and products involving botanical oils derived from cannabis and algae. The original core of the company’s product development strategy was the extraction of Omega-3 fatty acids from certain strains of algae with high concentrations of DHA to create various nutraceutical products. As a result of the many demonstrated health benefits of other botanical oils, most notably cannabis oil, Algae Dynamics developed a strategy aimed at developing products that combined the health benefits of algae and cannabis oils. Capitalizing on the burgeoning demand for cannabis oil and other smoke-free alternatives…

ThursdayJun 15, 2017 8:00 am

Pharmaceutical Leaders Pave the Way to New Alzheimer’s Treatments

PsychedelicNewsWire Editorial Coverage: Alzheimer’s disease is a devastating brain disorder that now affects about 5.3 million Americans, accounting for one in nine people over the age of 65, according to the Alzheimer’s Association. One in three seniors die with the disease or another form of dementia, and, while treatments to slow or stop the disease’s progression have been lacking, several pharmaceutical companies are working to change that. India Globalization Capital, Inc. (NYSE: IGC) (IGC Profile), which has products that are backed by data of cannabis-based combination therapies to treat Alzheimer’s, pain, seizures and a host of neurological and oncological issues,…

TuesdayJun 06, 2017 3:05 pm

India Globalization Capital, Inc. (NYSE: IGC) Targets Human and Veterinary Epilepsy with Innovative Cannabinoid Therapy

With about 50 million people affected worldwide, drug-resistant epilepsy, or refractory epilepsy, is a very serious condition for which a medical solution has not yet been found, but the therapeutic benefits of phytocannabinoid-based therapies for seizures have been coming under increased scrutiny lately. There is mounting evidence that cannabinoid extracts, and in particular cannabidiol (CBD), can have a positive impact on epilepsy patients and alleviate seizures, as indicated by recent research. Companies such as India Globalization Capital, Inc. (NYSE MKT: IGC) are at the forefront of discovering cannabinoid-based epilepsy treatments for humans and animals alike, by developing innovative formulations that…

WednesdayMay 24, 2017 9:00 am

Evolution of Marijuana Industry Creates Wealth of Opportunity for Companies with Foresight and Action

PsychedelicNewsWire Editorial Coverage: The marijuana industry continues to evolve at a breakneck pace in the United States, and an increasing number of businesses are finding their niche in this rampant market as it burns toward nationwide legalization. In the wake of this evolution, various new types of businesses are emerging to provide the consumer and commercial markets with products and services such as branding and packaging, smoke lounges, cultivation operations, grow equipment, pain management, payment solutions and numerous others. SinglePoint, Inc. (SING) (SING Profile), Medical Marijuana, Inc. (MJNA), Kush Bottles, Inc. (KSHB), Scott’s Miracle-Gro Co. (SMG) and Canopy Growth Corp.…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000